genprowebdirectory
Facebook
Linkedin
RSS
Twitter
Youtube
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Facebook
Linkedin
RSS
Twitter
Youtube
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
2023
Arena Pharmaceuticals
Drug Discovery
Abivax Advances Ulcerative Colitis Candidate with U.S. IPO
Drug Discovery
Wider Arena: Aristea Pursues Excellence with $123M in Investment
Industry News
Arena Pharmaceuticals Axing 100 Employees, 73% of Workforce
Drug Discovery
Boehringer Ingelheim, Arena Launch Up-to-$262M Psychiatric Drug Collaboration
Industry News
Arena Pharma Cutting 80 U.S. Jobs
News
Ildong Inks Another License Agreement in South Korea
News
Arena, Eisai Win FDA Okay for Obesity Drug
Insights
Regulatory Environment Warms Up to Obesity Drugs
Insights
Regulatory Environment Warms Up to Obesity Drugs and Could Heat Up Market
Industry News
Obesity-Focused Firm Ablaris Adds $1.2M to Series A Financing
1
2
3
Page 1 of 3
Scroll Up
Scroll Up
